Mrs Ami Petosa Myers, MS, OTR/L | |
750 E Adams St, Syracuse, NY 13210-2306 | |
(315) 464-4000 | |
Not Available |
Full Name | Mrs Ami Petosa Myers |
---|---|
Gender | Female |
Speciality | Occupational Therapist |
Location | 750 E Adams St, Syracuse, New York |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1053834507 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225X00000X | Occupational Therapist | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Ami Petosa Myers, MS, OTR/L 1310 Bargeview Dr, Chittenango, NY 13037-9504 Ph: () - | Mrs Ami Petosa Myers, MS, OTR/L 750 E Adams St, Syracuse, NY 13210-2306 Ph: (315) 464-4000 |
News Archive
Texas Biomedical Research Institute in San Antonio, Texas, was awarded $1 million from the Bill & Melinda Gates Foundation to test the efficacy of human monoclonal antibodies (MAbs) for the treatment of SARS-CoV-2 infection.
Imagenetix, Inc. (OTC Bulletin Board: IAGX) announced that InflameAway Celadrin(R) extra strength soft gels for joint health are currently available at the nation's number one drug chain, the number one and number two supermarket stores and the number one club warehouse store. This retail distribution provides a platform for future retail gains as well as additional product launches, including a 100 count value size.
Startling new statistics on the worldwide prevalence of Alzheimer's disease and related dementias are being released today as countries across the globe join together in recognition of World Alzheimer's Day.
A new international study for women with HER2-positive breast cancer is open for enrollment. The pivotal BETH (BEvacizumab and Trastuzumab Adjuvant Therapy in HER2-positive Breast Cancer) study is a Phase III clinical research trial that is investigating the benefits of combining two monoclonal antibodies, the anti-angiogenic, bevacizumab (Avastin) and the targeted therapy trastuzumab (Herceptin), together with chemotherapy for the treatment of patients with early stage HER2-positive breast cancer.
› Verified 6 days ago
Mrs. Lisa Marie Searles, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 110 Elmtree Lane, Syracuse, NY 13219 Phone: 315-263-3272 | |
Ianna Javier Garcia, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4900 Broad Rd, Syracuse, NY 13215 Phone: 315-492-5011 | |
Kristina Schuler, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 171 Intrepid Ln, Syracuse, NY 13205 Phone: 315-437-4689 | |
Morgan Ruggeri, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 1603 Court St, Syracuse, NY 13208 Phone: 315-455-7591 | |
Ms. Katherine Janice Bufano, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 800 Irving Ave, Veteran's Adm. Medical Center-occupational Therapy, Syracuse, NY 13210 Phone: 315-425-4400 Fax: 315-425-2685 | |
Ms. Christine Cantine Lighthipe, MS ED. OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 750 E Adams St, Syracuse, NY 13210 Phone: 315-464-2300 Fax: 315-464-2305 | |
Mrs. Kelly Ann Lugert, OTRL Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 700 E Brighton Ave, Syracuse, NY 13205 Phone: 315-413-3279 |